| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Immuron Limited (NASDAQ: IMRN)
IMRN Technical Analysis
5
| As on 9th Jun 2023 IMRN STOCK Price closed @ 1.86 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.68 & Strong Sell for SHORT-TERM with Stoploss of 3.17 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IMRNSTOCK Price
| Open | 1.96 | Change | Price | % |
| High | 1.96 | 1 Day | -0.12 | -6.06 |
| Low | 1.85 | 1 Week | -0.24 | -11.43 |
| Close | 1.86 | 1 Month | -0.35 | -15.84 |
| Volume | 31400 | 1 Year | -1.00 | -34.97 |
| 52 Week High 4.23 | 52 Week Low 1.61 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| IMRN Daily Charts |
IMRN Intraday Charts |
Whats New @ Bazaartrend |
IMRN Free Analysis |
|
|
IMRN Important Levels Intraday
| RESISTANCE | 2.07 |
| RESISTANCE | 2.00 |
| RESISTANCE | 1.96 |
| RESISTANCE | 1.92 |
| SUPPORT | 1.80 |
| SUPPORT | 1.76 |
| SUPPORT | 1.72 |
| SUPPORT | 1.65 |
IMRN Forecast May 2024
| 4th UP Forecast | 5.5 |
| 3rd UP Forecast | 4.33 |
| 2nd UP Forecast | 3.61 |
| 1st UP Forecast | 2.89 |
| 1st DOWN Forecast | 0.83 |
| 2nd DOWN Forecast | 0.11 |
| 3rd DOWN Forecast | -0.61 |
| 4th DOWN Forecast | -1.78 |
IMRN Weekly Forecast
| 4th UP Forecast | 2.82 |
| 3rd UP Forecast | 2.51 |
| 2nd UP Forecast | 2.32 |
| 1st UP Forecast | 2.13 |
| 1st DOWN Forecast | 1.59 |
| 2nd DOWN Forecast | 1.40 |
| 3rd DOWN Forecast | 1.21 |
| 4th DOWN Forecast | 0.90 |
IMRN Forecast2024
| 4th UP Forecast | 7.64 |
| 3rd UP Forecast | 5.79 |
| 2nd UP Forecast | 4.64 |
| 1st UP Forecast | 3.5 |
| 1st DOWN Forecast | 0.23 |
| 2nd DOWN Forecast | -0.92 |
| 3rd DOWN Forecast | -2.07 |
| 4th DOWN Forecast | -3.92 |
Immuron Limited ( NASDAQ USA Symbol : IMRN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IMRN Business Profile
Immuron Limited, a biopharmaceutical company, researches, develops, and commercializes polyclonal antibodies in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It markets Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and reduce the symptoms of minor gastro-intestinal disorders, as well as for dietary supplement for digestive tract protection; and Protectyn, an immune supplement to maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) that is in Phase III clinical trials to reduce the risk of contracting travelers' diarrhea, as well as acts as an anti-viral activity against SARS-CoV-2; and IMM-529, which is in clinical development stage focuses on treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and ETEC infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is based in Carlton, Australia. Address: 25-37 Chapman Street, Carlton, VIC, Australia, 3130
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service